Lucid Capital Markets analyst Elemer Piros downgraded Passage Bio Inc. (NASDAQ: PASG) from Buy to Neutral with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Downgrades